Concepedia

Whitney Kilu

WK

Statistics

Publications

11

Citations

369

H-Index

11

Active since

2019

Affiliations

Fraunhofer Institute for Translational Medicine and Pharmacology(Current)

Goethe University Frankfurt

Fraunhofer Institute for Molecular Biology and Applied Ecology

Ludwig-Maximilians-Universität München

Whitney Kilu is an author at Fraunhofer Institute for Translational Medicine and Pharmacology specializing in pharmacology, ligand binding, and nuclear receptors.

ORCID

Publications per year

2019–2022

11

Publications

11

The orphan nuclear receptor Nurr1 is responsive to non-steroidal anti-inflammatory drugs

Sabine Willems, Whitney Kilu, Xiaomin Ni et al. · Communications Chemistry · 2020 · 66 citations · Full text

, , +17

Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation

Julius Pollinger, Leonie Gellrich, Simone Schierle et al. · Journal of Medicinal Chemistry · 2019 · 54 citations · Full text

, , +16

<scp>l</scp>-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ

Leonie Gellrich, Pascal Heitel, Jan Heering et al. · Journal of Medicinal Chemistry · 2020 · 49 citations · Full text

, , +17

Nurr1 Modulation Mediates Neuroprotective Effects of Statins

Sabine Willems, Julian A. Marschner, Whitney Kilu et al. · Advanced Science · 2022 · 39 citations · Full text

, , +17

Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγ

Whitney Kilu, Daniel Merk, Dieter Steinhilber et al. · Journal of Biological Chemistry · 2021 · 34 citations · Full text

, , +17

1–5 of 11